EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 199 filers reported holding EDITAS MEDICINE INC in Q1 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $275 | -99.9% | 33,355 | +7.4% | 0.02% | -40.0% |
| Q3 2022 | $380,000 | +1.1% | 31,055 | -2.4% | 0.04% | +9.4% |
| Q2 2022 | $376,000 | -82.1% | 31,812 | -37.8% | 0.03% | -82.7% |
| Q3 2021 | $2,102,000 | +160.5% | 51,160 | +166.4% | 0.18% | +224.6% |
| Q1 2021 | $807,000 | -39.3% | 19,203 | +1.3% | 0.06% | -60.1% |
| Q4 2020 | $1,329,000 | +163.7% | 18,959 | +5.6% | 0.14% | +66.3% |
| Q3 2020 | $504,000 | -52.0% | 17,947 | -49.4% | 0.09% | -28.9% |
| Q2 2020 | $1,050,000 | +96.3% | 35,503 | +96.5% | 0.12% | +132.7% |
| Q4 2019 | $535,000 | +164.9% | 18,068 | +103.1% | 0.05% | +372.7% |
| Q4 2018 | $202,000 | -33.1% | 8,896 | -6.2% | 0.01% | -38.9% |
| Q3 2018 | $302,000 | -30.6% | 9,482 | -21.9% | 0.02% | -5.3% |
| Q2 2018 | $435,000 | -24.5% | 12,145 | -30.1% | 0.02% | -38.7% |
| Q1 2018 | $576,000 | – | 17,364 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |